Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
=====Anti-CD20 [[Monoclonal Antibody]]===== | =====Anti-CD20 [[Monoclonal Antibody]]===== | ||
* [[Arzerra]] - Generic: [[Ofatumumab]] | * [[Arzerra]] - Generic: [[Ofatumumab]] | ||
| - | * [[Rituxan]] - Generic: Rituximab | + | * [[Rituxan]] - Generic: [[Rituximab]] |
=====Anti-melanoma [[Monoclonal Antibody]]===== | =====Anti-melanoma [[Monoclonal Antibody]]===== | ||
* Pembrolizumab - Generic: [[Keytruda]] | * Pembrolizumab - Generic: [[Keytruda]] | ||
Revision as of 11:12, 5 February 2019
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor ModulatorMultiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
